Most Alzheimer's medications — donepezil, rivastigmine, galantamine and memantine — can be taken with or without food; there is no meal-timing requirement on the FDA labels. The sleep medication suvorexant is different: it is taken 30 minutes before bedtime, and its interactions with CYP3A-affecting drugs and foods should be reviewed with the pharmacist. Long-term use of several common medicines can also affect micronutrient status, so regular review of labs and diet matters for older adults with dementia.
A 2023 primer in the Journal of Neurosciences in Rural Practice categorizes FDA-approved Alzheimer's drugs into symptom-mitigating agents (cholinesterase inhibitors, glutamate regulators) and disease-modifying therapies (aducanumab, lecanemab). Its dosing details and the FDA labels give clear food guidance:
5 or 10 mg once daily (or transdermal patch). No food-timing requirement — take it consistently, at the same time each day.
Oral: 1.5–6 mg twice daily, or 4.6–17.4 mg/24h patch. No food-timing requirement — the label lists no food interaction.
16–24 mg/day (twice-daily or extended-release). No food-timing requirement — the label lists no food interaction.
10 mg once daily (immediate or sustained release). The label notes that urine pH — influenced by diet, some drugs and clinical state — can alter memantine elimination; a dramatically shifted diet should be mentioned to the care team.
The 2023 primer lists suvorexant (5–20 mg) taken 30 minutes before bedtime. Its clearance involves CYP3A, so the primer flags drug-drug interactions with CYP3A inhibitors — including grapefruit juice in some cases — that should be reviewed with the pharmacist before adding anything new to the routine.
A 2020 review in Critical Reviews in Food Science and Nutrition stresses that widely prescribed drugs can contribute to micronutrient deficiencies, and that clinicians and pharmacists should actively look for them. For older adults on multiple medications, this is a practical reminder: routine labs, vitamin B12 and vitamin D status, and any unexplained fatigue or appetite change are worth raising with the care team — and a pharmacist can help map which medicines might be involved.